Glyset (miglitol), a new drug for type 2 diabetes

February 1999

Pharmacia & Upjohn is marketing Glyset (miglitol), a new drug for type 2 diabetes.

Glyset is a "me-too"...very similar to Precose (acarbose).

Both can be used as initial therapy...or combined with other meds for type 2 diabetes.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

drug reps to give out information about unapproved uses of their prescription drugs
Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market
Neurology & Pain new CNS stimulant called Provigil (modafinil)
Lovenox (enoxaparin) is now approved to TREAT blood clots
new drug for intermittent claudication
Gastroenterology new guidelines for treating H. pylori
Diabetes Glyset (miglitol), a new drug for type 2 diabetes
Diabetes mix Humalog (lispro) with long-acting insulins
Diabetes Fenugreek supplements (Limitrol-DM, etc) are now being promoted to lower blood sugar
Women's Health Prometrium (micronized progesterone) is now APPROVED for hormone replacement therapy (HRT)
Women's Health more attention focused on urinary incontinence
new drug for HIV, Ziagen (abacavir)
Infectious Diseases Lymerix, the first vaccine to prevent Lyme disease
Infectious Diseases minocycline is useful for mild to moderate scleroderma
Infectious Diseases Herp-Eeze, a new herbal supplement promoted for herpes
Generics two significant new generics
Practice chart of new drugs approved by the FDA in 1998